| Product Code: ETC6357356 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Lumasiran Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Lumasiran Market - Industry Life Cycle |
3.4 Belgium Lumasiran Market - Porter's Five Forces |
3.5 Belgium Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Belgium Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Belgium Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Belgium Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Belgium Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Belgium Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Belgium Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of rare diseases in Belgium |
4.2.2 Growing demand for innovative treatments in the healthcare sector |
4.2.3 Favorable government regulations supporting the development and adoption of orphan drugs |
4.2.4 Rising investments in research and development for rare disease treatments |
4.3 Market Restraints |
4.3.1 High cost of treatment and limited insurance coverage for orphan drugs |
4.3.2 Limited patient population for specific rare diseases targeted by lumasiran |
4.3.3 Stringent regulatory requirements for approval of orphan drugs in Belgium |
4.3.4 Competition from existing treatment options for rare diseases |
5 Belgium Lumasiran Market Trends |
6 Belgium Lumasiran Market, By Types |
6.1 Belgium Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Belgium Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Belgium Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Belgium Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Belgium Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Belgium Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Belgium Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Belgium Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Belgium Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Belgium Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Belgium Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Belgium Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Belgium Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Belgium Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Belgium Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Belgium Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Belgium Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Belgium Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Belgium Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Belgium Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Belgium Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Belgium Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Belgium Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Belgium Lumasiran Market Import-Export Trade Statistics |
7.1 Belgium Lumasiran Market Export to Major Countries |
7.2 Belgium Lumasiran Market Imports from Major Countries |
8 Belgium Lumasiran Market Key Performance Indicators |
8.1 Number of patients diagnosed with rare diseases in Belgium |
8.2 Rate of adoption of innovative treatments in the healthcare sector |
8.3 Success rate of clinical trials for orphan drugs |
8.4 Investment in research and development for rare disease treatments |
8.5 Patient satisfaction and quality of life improvements with the use of lumasiran |
9 Belgium Lumasiran Market - Opportunity Assessment |
9.1 Belgium Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Belgium Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Belgium Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Belgium Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Belgium Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Belgium Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Belgium Lumasiran Market - Competitive Landscape |
10.1 Belgium Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Belgium Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here